Prognostic factors in oligometastatic non-small-cell lung cancer (OM-NSCLC) patients treated with ablative therapy

Authors :: E. Navarro
Nuria Mancheño
Oscar Juan Vidal
David Lorente
Domingo Benjamín
Corina Escoin
Carmen Salvador
Juan Antonio Mendez
José Gómez-Codina
Marcos Melian
Source :: Journal of Clinical Oncology. 36:e21089-e21089
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: e21089Background: OM-NSCLC represents a distinct prognostic group within stage IV lung cancer. Prognostic factors influencing outcome in these patients are not well-known. Methods: We analyzed 84 O...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
medicine.disease
respiratory tract diseases
030218 nuclear medicine & medical imaging
03 medical and health sciences
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
Ablative case
medicine
Non small cell
Prognostic group
Stage iv
business
Lung cancer

Full Text Access

Tools